What is DNLI's dilution risk score?

DNLI has a latest available DilutionScore record of 31/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for DNLI, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for DNLI?

DilutionWatch tracks 25 SEC filing types for DNLI including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect DNLI shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For DNLI, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for DNLI tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for DNLI. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

DNLI Dilution Risk Score: 31/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

25

📊 Float Risk

7

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for DNLI.

🔔 Track DNLI — Get forecast alerts →

Market Data

Market Cap$3.34B

Shares Outstanding159.85M

Float144.27M

Cash$710.47M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 11.4% shares (2026Q1 vs prior)

272 institutional holders · 172.66M shares

#1 BlackRock, Inc. 13.03M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 12.30M shares

#3 BAILLIE GIFFORD & CO 12.07M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest17.43M

Days to Cover12.1

% of Float12.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2017-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual DNLI Dilution Snapshot

Denali Therapeutics Inc. (DNLI) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for DNLI: xbrl on 2017-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.